Centrum 7/6  banner

HDA issues statement on FDA distributor licensure proposed rule

Print Friendly, PDF & Email

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) released the following statement from president and CEO Chester “Chip” Davis Jr., regarding FDA’s proposed rule, issued as required by the Drug Supply Chain Security Act (DSCSA), entitled “National Standards for Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers”:

Chip Davis

“HDA has long supported thorough, rigorous and uniform standards for state licensing of healthcare distributors and third-party logistics providers to help ensure that criminals do not infiltrate the supply chain and unlawfully gain access to prescription medications.

“While we are continuing to analyze the proposed standards, HDA is pleased that FDA has recognized the need for a uniform licensing framework across all 50 states and has reinforced the DSCSA’s elimination of the patchwork of state requirements that currently exists.

“Health care distributors anticipate that once the rules are finalized, they will enhance the security and efficiency of the supply chain and expedite the delivery of vital medicines, vaccines and healthcare products to practitioners, dispensers and, ultimately, the patients who need them.

“HDA looks forward to taking a closer look at the proposed standards to fully understand the requirements and their impact on the supply chain and will provide public comments accordingly.”


ECRM_06-01-22


Comments are closed.

PP_1170x120_10-25-21